This study utilizes scRNA-seq and machine learning technologies to demonstrate that interactions between ECs and FBs mediated by SCARB1 receptors on ECs represent a viable target for managing progressive heart failure with cardiac hypertrophy. The gene discussed is SCARB1; the disease is heart failure.